<SEC-DOCUMENT>0001999371-25-014969.txt : 20251008
<SEC-HEADER>0001999371-25-014969.hdr.sgml : 20251008
<ACCEPTANCE-DATETIME>20251008171925
ACCESSION NUMBER:		0001999371-25-014969
CONFORMED SUBMISSION TYPE:	497AD
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251008
DATE AS OF CHANGE:		20251008

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nuveen Global High Income Fund
		CENTRAL INDEX KEY:			0001615905
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		497AD
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287584
		FILM NUMBER:		251383147

	BUSINESS ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-917-8146

	MAIL ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>497AD
<SEQUENCE>1
<FILENAME>jgh_497ad-100825.htm
<DESCRIPTION>FILING BY CERTAIN INVESTMENT COMPANIES OF SECURITIES ACT RULE 482 ADVERTISING
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 16pt Times New Roman, Times, Serif; color: #008FBE; margin: 12pt 0 0"><IMG SRC="nuveenlogo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: bold 16pt Georgia, Times, Serif; color: #008FBE; margin: 12pt 0 0">Nuveen Global High Income Fund Announces Terms of Rights
Offering</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"><B>CHICAGO, October 8, 2025</B> &ndash; Nuveen Global High Income Fund (NYSE:
JGH) today announced that its Board of Trustees (the &ldquo;Board&rdquo;) has approved the terms of the issuance of transferable rights
(&ldquo;Rights&rdquo;) to the holders of the Fund&rsquo;s common shares (par value $.01 per share) (&ldquo;Common Shares&rdquo;) as of
October 21, 2025 (the &ldquo;Record Date&rdquo;). Holders of Rights will be entitled to subscribe for additional Common Shares (the &ldquo;Offer&rdquo;)
at a subscription price that is expected to represent a discount to the market price of the Common Shares.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"><FONT STYLE="background-color: white">After considering a number of factors,
including potential benefits and costs, the Board and the Fund&rsquo;s investment adviser, Nuveen Fund Advisors, LLC (the &ldquo;Adviser&rdquo;),
have determined that the Offer will benefit both the Fund and its shareholders and increase the assets of the Fund available to take advantage
of existing investment opportunities, consistent with the Fund&rsquo;s investment objective of providing shareholders with a high level
of current income.</FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"><FONT STYLE="background-color: white"><B>All expenses of the Offer will
be borne by the Adviser, and not by the Fund or any of the Fund's shareholders.</B></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"><FONT STYLE="background-color: white">The Adviser believes this is an attractive
time to raise additional assets for the Fund based on several factors, including the following potential benefits:</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><B>Portfolio opportunities: </B>attractive valuations and yields in certain global high-income asset classes provides the potential to enhance portfolio yields and fund earnings while improving the potential for investment performance for all common shareholders</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><B>Tax-efficiency: </B>potential to re-balance the portfolio to new opportunities without the need to sell existing portfolio positions, which may reduce taxable events for common shareholders</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><B>Benefit for common shareholders:</B>&nbsp;the Offer provides common shareholders with an opportunity to buy new Common Shares below market price </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><B>Enhanced liquidity:</B>&nbsp;the Offer creates the potential for increased trading volume and liquidity of Common Shares</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><B>Lower expense ratio:</B>&nbsp;the Offer is expected to spread fixed operating costs across a larger asset base</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 12pt 0 0; color: #008FBE"><IMG SRC="nuveenlogo.jpg" ALT="">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt; background-color: white">Certain key terms of the Offer include:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Holders of Common Shares on the Record Date (&ldquo;Record Date Shareholders&rdquo;) will receive one Right for each outstanding Common Share owned on the Record Date. The Rights entitle the holders to purchase one new Common Share for every four Rights held&nbsp;(1-for-4).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">The subscription price per Common Share (the &ldquo;Subscription Price&rdquo;) will be determined based upon a formula equal to 95% of the average of the last reported sales price of the Common Shares on the NYSE on the Expiration Date and each of the four (4) preceding trading days (the &ldquo;Formula Price&rdquo;). If, however, the Formula Price is less than 90% of the net asset value per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund&rsquo;s net asset value per Common Share at the close of trading on the NYSE on the Expiration Date. The Rights offering will expire at 5:00 p.m., Eastern time, on November 20, 2025 (the &ldquo;Expiration Date&rdquo;).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Record Date Shareholders who fully exercise all Rights issued to them can subscribe, subject to certain limitations and allotment, for any additional Common Shares which were not subscribed for by other holders of Rights at the Subscription Price, subject to the right of the Board to eliminate this over-subscription privilege. <B>Investors who are not Record Date Shareholders but who otherwise acquire Rights in the secondary market are not entitled to participate in the over-subscription privilege.</B> If these requests exceed available Common Shares, they will be allocated pro rata among those fully exercising Record Date Shareholders who over-subscribe based on the number of Rights originally issued to them by the Fund.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Georgia, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&bull;</TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Rights are transferable and are expected to be admitted for trading on the NYSE under the symbol &ldquo;JGH RTWI&rdquo; initially trading &ldquo;when-issued&rdquo; on October 20, 2025. The Rights are expected to begin trading with regular settlement under the symbol &ldquo;JGH RT&rdquo; on or about October 23, 2025, and are expected to cease trading at the close on November 19, 2025, one day before the Offer&rsquo;s Expiration Date. During this time, Record Date Shareholders may also choose to sell their Rights. <B>There is no guarantee that a market for the Rights will develop or be maintained.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0; background-color: white">The Fund has declared or expects to declare monthly
distributions payable on November 3, 2025 and December 1, 2025, with record dates of October 15, 2025 and November 14, 2025, respectively.
<B>Any Common Shares issued after such record dates as a result of the Rights offering will not be record date Common Shares for the Fund&rsquo;s
monthly distributions to be paid on November 3, 2025 and December 1, 2025 and will not be entitled to receive such distributions.</B>
Shares issued pursuant to the Offer will be entitled to receive the monthly distribution expected to be payable on December 31, 2025.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0pt; background-color: white">The Offer will be made only by means of a prospectus
supplement and accompanying prospectus. The final terms of the Offer may be different from those set out above and the terms included
in the prospectus supplement and accompanying prospectus will control.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0in; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 12pt 0 0; color: #008FBE"><IMG SRC="nuveenlogo.jpg" ALT="">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0in; background-color: white"><B>The information in this press release is
not complete and is subject to change. This document is not an offer to sell any securities and is not soliciting an offer to buy
any securities in any jurisdiction where the offer or sale is not permitted. This document is not an offering, which can only be
made by a prospectus. Investors should consider the Fund&rsquo;s investment objective, risks, charges and expenses carefully before
investing. The Fund&rsquo;s prospectus supplement and accompanying prospectus will contain this and additional information about the
Fund and additional information about the Offer, and should be read carefully before investing. For further information regarding
the Offer, or to obtain a prospectus supplement and the accompanying prospectus, when available, please contact the Fund&rsquo;s
information agent:</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 12pt 0 0; background-color: white">Georgeson LLC:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">866-989-7750</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">Nuveen is a leading sponsor of closed-end funds (CEFs) with $52 billion
in assets under management across 45 CEFs as of 30 Jun 2025. The funds offer exposure to a broad range of asset classes and are designed
for income-focused investors seeking regular distributions. Nuveen has more than 35 years of experience managing CEFs.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">For more information, please visit Nuveen&rsquo;s CEF homepage www.nuveen.com/closed-end-funds
or contact:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">Financial Professionals:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">800-752-8700</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">Investors:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">800-257-8787</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">Media:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 0pt">media-inquiries@nuveen.com</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 0pt">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0in"><B></B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 12pt 0 0; color: #008FBE"><IMG SRC="nuveenlogo.jpg" ALT="">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"><B>About Nuveen</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0"><FONT STYLE="color: #212121">Nuveen is a global
investment leader, managing $1.3T in public and private assets for clients around the world, as of 30 Jun 2025. With broad expertise across
income and alternatives, we invest in the growth of businesses, real estate, infrastructure, and natural capital, providing clients with
the reliability, access, and foresight unique to our 125+ year heritage. Our prevailing perspective on the future drives our ambition
to innovate and adapt our business to the changing needs of investors &mdash; all to pursue lasting performance for our clients, our communities,
and our global economy. </FONT>For more information, please visit www.nuveen.com.
Nuveen Securities, LLC, member FINRA and SIPC.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0">The information contained on the Nuveen website
is not a part of this press release.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">Certain statements made in this release are forward-looking statements.
Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements due to
numerous factors. These include, but are not limited to:</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0px; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">market developments;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0px; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">legal and regulatory developments; and</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0px; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 35pt; text-align: right">&bull;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">other additional risks and uncertainties.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">You should not place undue reliance on forward-looking statements, which speak
only as of the date they are made. Nuveen and the closed-end funds managed by Nuveen and its affiliates undertake no responsibility to
update publicly or revise any forward-looking statements.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">The annual and semi-annual reports and other regulatory filings of Nuveen closed-end
funds with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) are accessible on the SEC&rsquo;s web site at www.sec.gov and on
Nuveen&rsquo;s website at www.nuveen.com/cef and may discuss the above-mentioned or other factors that affect Nuveen closed-end funds.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; background-color: white"><B>Important information
on risk</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; background-color: white"><B>Past performance
is no guarantee of future results. All investments carry a certain degree of risk, including the possible loss of principal, and there
is no assurance that an investment will provide positive performance over any period of time. Certain products and services may not be
available to all entities or persons. There is no guarantee that investment objectives will be achieved.</B></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; background-color: white">Closed-end funds
frequently trade at a discount from net asset value (NAV). At any point in time, including when sold, shares may be worth more or less
than the purchase price or the net asset value, even after considering the reinvestment of fund distributions. It is important to consider
the objectives, risks, charges and expenses of any fund before investing.</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt">4881784</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 0pt; text-align: center">###</P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0 0 12pt"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>nuveenlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nuveenlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+L17AI9@  34T *@    @ ! $[  (
M   +   !2H=I  0    !   !5IR=  $    6   "SNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M5VEN9R!$=6]N9P    60 P "    %    J20!  "    %    KB2D0 "
M S,P  "2D@ "     S,P  #J'  '   !#    9@     '.H    !
M
M
M
M
M
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
